<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04345835</url>
  </required_header>
  <id_info>
    <org_study_id>RS/19.20</org_study_id>
    <nct_id>NCT04345835</nct_id>
  </id_info>
  <brief_title>Prone Flexed Position in Percutanous Nephrolithotomy</brief_title>
  <official_title>Prone Flexed Position in Percutanous Nephrolithotomy in Comparsion With Standard Prone Position. A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kafrelsheikh University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kafrelsheikh University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      prone flexed position in percutanous nephrolithotomy in comparsion with standard prone
      position. A randomized controlled trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients meeting the inclusion criteria will be randomly allocated to 2 groups:

        1. 1st group will undergo prone-flexed PCNL.

        2. 2nd group will undergo prone PCNL.

      III. Recruitment of participants Patients appointed for an outpatient diagnostic cystoscopy
      will be reviewed for the inclusion and exclusion criteria. Legible patients will be asked to
      participate in the study and to sign the informed consent form.

      IV. Randomisation Randomization will be performed using computer generated random tables
      using stratified blocked randomization in 1:1 ratio.

      V. Study procedure Preoperative evaluations included

        1. Detailed medical history

        2. Physical examination

        3. Routine blood examination

        4. Urinalysis &amp; urine cytology

        5. Renal and liver function tests

        6. Coagulation profile

      8. Computed tomography of the abdomen and pelvis

      Operative Technique

      Prone-flexed positioning i. Retrograde access will be obtained ii. The patient is
      repositioned prone with adequate padding under the pressure points of the head, chest, knees,
      and feet.

      iii. The table is flexed 30 degrees at the level of the patient's mid lumbar region to open
      the space between the 12th rib and the posterior iliac crest dropping the gluteal muscles
      from the working plane.

      Ancillary intervention

      Patients will receive a 20-mL infiltration of 0.25% bupivacaine. Under fluoroscopic guidance,
      the local analgesic was infiltrated with a 22-gauge spinal needle (10-cm length) along the
      nephrostomy tract at the 3, 6, 9, and 12 o'clock positions (5 mL in each tract), including
      the muscles, subcutaneous tissue, and skin.

      Patients will receive 1 g tranexamic acid at induction followed by three further doses of 500
      mg over the next 24 h.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Actual">April 1, 2020</completion_date>
  <primary_completion_date type="Actual">April 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>position complications</measure>
    <time_frame>end of the study</time_frame>
    <description>Comparing the prone with the prone-flexed position for PCNL reporting complications using the Clavien-Dindo system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stone score system</measure>
    <time_frame>end of the study</time_frame>
    <description>Comparison of the Guy's (19)&quot; combines the number of stones, their location, and abnormal patient anatomy into a score 1-4&quot;, S.T.O.N.E. (20)&quot;uses the stone size, tract length, obstruction, number of calyces involved, and stone density from patient's preoperative CT scan&quot;, and CROES (21) &quot;a continuous variable calculated by stone characteristics, patient data, and surgeon/centre experience&quot; Scores for predicting outcomes following PCNL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stone characteristics</measure>
    <time_frame>end of the study</time_frame>
    <description>Explore the relationship between stone density using various HU values &quot;highest HU value (HUmax), lowest HU value (HUmin) and average HU value (HUave)&quot;on and outcomes of percutaneous nephrolithotomy (PCNL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stone volume</measure>
    <time_frame>end of the study</time_frame>
    <description>Assess the impact of the ellipsoid volume of the stone [volume = Ï€/6*(AP*H*CC)] after measuring the antero-posterior and horizontal dimensions in the axial images and the cranio-caudal dimension in the coronal images on and outcomes of percutaneous nephrolithotomy (PCNL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemostatic measures</measure>
    <time_frame>end of the study</time_frame>
    <description>Investigate the effect of antifibrinolytic tranexamic acid usage on blood loss during PCNL.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Renal Stones</condition>
  <arm_group>
    <arm_group_label>prone flexed</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>prone flexed PCNL position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>prone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>prone position PCNL</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutanous nephrolithotomy (PCNL)</intervention_name>
    <description>different procedure positioning</description>
    <arm_group_label>prone</arm_group_label>
    <arm_group_label>prone flexed</arm_group_label>
    <other_name>PNL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Large renal or upper ureteral calculi or both,

        Exclusion Criteria:

          -  (1) Age &lt;18 years or Pregnancy (2) Ureter pelvic junction obstruction (3) Bilateral
             simultaneous PCNL (4) Need for 3 percutaneous tracts intraoperative (5) Morbid obesity
             (BMI &gt;40) (6) Non opaque renal stones. (7)Refuse to complete study requirements
             (8)Untreated UTI (9)Atypical bowel interposition by CT (10)Tumour in the presumptive
             access tract area or Potential malignant kidney tumour
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diaa Eldin Taha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer of urology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kafrelsheikh faculty of medicine</name>
      <address>
        <city>Kafr Ash Shaykh</city>
        <state>Kafrelsheikh</state>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 12, 2020</study_first_submitted>
  <study_first_submitted_qc>April 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2020</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kafrelsheikh University</investigator_affiliation>
    <investigator_full_name>Diaa Eldin Taha Ramadan Mohamed</investigator_full_name>
    <investigator_title>Lecturer of urology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Calculi</mesh_term>
    <mesh_term>Nephrolithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

